Covered recipient · General Payments record
MEGHAN LINDSAY LYERLY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,782.63
- Reported across 423 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $778.23 | 55 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $333.64 | 28 |
| PFIZER INC. | $186.22 | 12 |
| Acerta Pharma LLC | $71.23 | 5 |
| GlaxoSmithKline, LLC. | $62.78 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.20 | 2 |
| Medtronic, Inc. | $30.70 | 1 |
| Abbott Laboratories | $22.95 | 1 |
| Novo Nordisk AS | $19.09 | 1 |
| Axsome Therapeutics, Inc. | $18.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.95 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125234321 | CMS |
| ABBVIE INC. | $4.09 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914883 | CMS |
| ABBVIE INC. | $12.20 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914885 | CMS |
| ABBVIE INC. | $20.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914887 | CMS |
| ABBVIE INC. | $1.69 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914889 | CMS |
| ABBVIE INC. | $19.42 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914891 | CMS |
| ABBVIE INC. | $3.26 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914893 | CMS |
| ABBVIE INC. | $1.56 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914895 | CMS |
| ABBVIE INC. | $15.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914897 | CMS |
| ABBVIE INC. | $12.56 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914899 | CMS |
| ABBVIE INC. | $14.86 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914901 | CMS |
| ABBVIE INC. | $2.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914903 | CMS |
| ABBVIE INC. | $6.46 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914905 | CMS |
| ABBVIE INC. | $2.40 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914907 | CMS |
| ABBVIE INC. | $34.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914909 | CMS |
| ABBVIE INC. | $6.03 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914911 | CMS |
| ABBVIE INC. | $16.67 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914913 | CMS |
| ABBVIE INC. | $15.94 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914915 | CMS |
| ABBVIE INC. | $7.59 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914917 | CMS |
| ABBVIE INC. | $5.75 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914919 | CMS |
| ABBVIE INC. | $15.91 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914921 | CMS |
| ABBVIE INC. | $33.29 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914923 | CMS |
| ABBVIE INC. | $22.27 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914925 | CMS |
| ABBVIE INC. | $10.09 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914927 | CMS |
| ABBVIE INC. | $4.63 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914929 | CMS |
| ABBVIE INC. | $11.74 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914931 | CMS |
| ABBVIE INC. | $7.90 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914933 | CMS |
| ABBVIE INC. | $20.04 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914935 | CMS |
| ABBVIE INC. | $4.40 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104914937 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.75 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105385170 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104328814 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105556886 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.26 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104376583 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.02 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105361512 | CMS |
| Axsome Therapeutics, Inc. | $18.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148303878 | CMS |
| GlaxoSmithKline, LLC. | $15.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116451355 | CMS |
| GlaxoSmithKline, LLC. | $13.66 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116140686 | CMS |
| GlaxoSmithKline, LLC. | $18.01 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116597697 | CMS |
| GlaxoSmithKline, LLC. | $15.96 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116664249 | CMS |
| Medtronic, Inc. | $30.70 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119464157 | CMS |
| Novo Nordisk Inc | $19.09 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097220190 | CMS |
| PFIZER INC. | $15.10 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130960628 | CMS |
| PFIZER INC. | $19.38 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131173861 | CMS |
| PFIZER INC. | $17.76 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131280494 | CMS |
| PFIZER INC. | $12.76 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131720074 | CMS |
| PFIZER INC. | $14.81 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131459654 | CMS |
| PFIZER INC. | $22.27 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131491520 | CMS |
| PFIZER INC. | $15.49 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131774233 | CMS |
| PFIZER INC. | $14.84 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131676971 | CMS |
| PFIZER INC. | $14.53 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131880137 | CMS |
| PFIZER INC. | $10.24 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131833450 | CMS |
| PFIZER INC. | $13.06 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130881800 | CMS |
| PFIZER INC. | $15.98 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131419076 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137625861 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.97 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137625864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.